Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Ritlecitinib effectively regrows hair in severe alopecia areata, especially in adolescents.

Certain hair and scalp features indicate a worse outcome in alopecia areata.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Vitamin D3 helps treat mild to moderate alopecia areata, especially when combined with other treatments.

Intralesional methotrexate and triamcinolone acetonide are more effective than Vitamin D3 for treating alopecia areata.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Minoxidil-dutasteride tattooing can potentially help regrow hair, especially in men who already have some thin hair.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

People with alopecia areata often have low vitamin D levels, which may worsen their hair loss.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib may help treat severe hair loss, but more research is needed.

Baricitinib is effective and safe for treating severe alopecia areata.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Alefacept does not effectively treat severe alopecia areata.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Baricitinib effectively reduces hair loss in severe alopecia areata and is generally safe.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.